Table 2.
Participant characteristics at baseline
| Subject no. | Gender (F/M) | Age | Weight (kg) | Stroke location, volume (ml)a | Days poststrokeb | NIHSSc | MRSd | FMMSc | Treatment cohort |
|---|---|---|---|---|---|---|---|---|---|
| 101 | M | 50 | 78 | Infarct, L, SC, 10.29 | 607 | 9 | 3 | 32 | A |
| 102 | M | 47 | 75 | Infarct, R, SC, 6.44 | 424 | 2 | 3 | 29 | A |
| 103e | M | 30 | 90 | Infarct, R, SC, 4.17 | 150 | 5 | 3 | 39 | A |
| 104e | M | 44 | 70 | Infarct, R, SC, 7.01 | 519 | 10 | 3 | 19 | B |
| 105e | M | 41 | 75 | Infarct, R, SC, 71.15 | 357 | 7 | 3 | 41 | B |
| 106 | M | 45 | 75 | Infarct, L, SC, 4.09 | 743 | 6 | 3 | 41 | B |
| 107 | M | 56 | 59 | Infarct, L, SC, 13.31 | 417 | 7 | 4 | 27 | C |
| 108 | M | 38 | 71 | Infarct, R, SC, 0.86 | 719 | 5 | 3 | 17 | C |
| 109 | F | 54 | 52 | Infarct, R, SC, 0.81 | 517 | 6 | 3 | 48 | C |
a
Volume was calculated in cubic centimeters from baseline T1 voxel counts in the lesion.
b
At the time of stem cell administration.
c
Determined at screen 2.
d
Determined at screen 1 (not performed at screen 2).
e
Withdrew consent after month 12 visit.
Abbreviations: F, female; FMMS, Fugl‐Meyer Motor Score; L, left; M, male; MRS, modified Rankin Score; NIHSS, National Institutes of Health Stroke Scale; R, right; SC, subcortical.